| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/24/2005 | US20050064411 Diagnostic probe for identifying ubiquitin ligase (NEDl-1) profile for use as diagnostic and prognostic indicator of cell proliferative disorders of nervous system |
| 03/24/2005 | US20050064410 Method and nucleic acids for the analysis of colon cancer |
| 03/24/2005 | US20050064407 Bcl-2 dnazymes |
| 03/24/2005 | US20050064406 Methods for high throughput genome analysis using restriction site tagged microarrays |
| 03/24/2005 | US20050064405 Nucleotide sequences coding metallo beta -lactamase (VDJ protein) for use as tool in diagnosis, treatment and prognosis of cell proliferative disorders |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064403 Novel Genes Encoding Novel Proteolytic Enzymes |
| 03/24/2005 | US20050064402 Tumor marker and methods of use |
| 03/24/2005 | US20050064401 Diagnosis of illnesses or predisposition to certain illnesses |
| 03/24/2005 | US20050064397 Method for mutation detection in HIV-1 using pol sequencing |
| 03/24/2005 | US20050064396 Cellular regulators of infectious agents and methods of use |
| 03/24/2005 | US20050064389 Chimeric lyssavirus nucleic acids and polypeptides |
| 03/24/2005 | US20050064341 Composition containing a photoacid generator monomer, substrate coated with the composition, method for synthesizing a compound on a substrate using the composition, and microarray produced according to the method |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063984 Antigenic peptide fragments of vapa protein, and uses thereof |
| 03/24/2005 | US20050063982 GRP94-based compositions and methods of use thereof |
| 03/24/2005 | US20050063973 An antibody that binds specifically to TMF/ARA160 protein; receptor binding assay; gene expression inhibition of Fer using RNA interference; drug screening; prostate cancer |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063970 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 03/24/2005 | US20050063962 Use of polarized light microscopy for visualization of the spindle body of a cell in metaphase during cell enucleation with minimal amount of cytoplasm; totipotent or pluripotent cells; cloned vertebrates |
| 03/24/2005 | US20050063961 Hematopoietic stem cells and endothelial progenitor cells; express the cell surface antigen CD31; delivering transgenes to the eye for cell-based gene therapy; treating ocular diseases such as retinopathy |
| 03/24/2005 | US20050063960 Dna construct for assessing thymic function activity and therapeutical uses thereof |
| 03/24/2005 | US20050063958 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme |
| 03/24/2005 | US20050063957 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 03/24/2005 | US20050063954 Recombinant reovirus for treating a Ras-mediated proliferative disorder such as tumors |
| 03/24/2005 | US20050063953 Adenoviral vector with replication-dependent transgene expression |
| 03/24/2005 | US20050063950 Cell-targeting ligand (e.g. transferrin) noncovalently bound directly to a virus; less inactivation of ligand than with conjugation; tissue targeted therapy; sensitizing cancer cells prior to chemotherapy or radiotherapy |
| 03/24/2005 | US20050063870 Biosensor and method of manufacturing biosensor |
| 03/24/2005 | DE10339927A1 Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen A composition for prophylaxis / therapy of HBV infection and HBV-mediated diseases |
| 03/24/2005 | DE10337770A1 Endothelial-cell specific gene-transfer system, useful for treating tumors, comprises virus that includes vascular endothelial growth factor in its capsid |
| 03/24/2005 | CA2578375A1 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | CA2568603A1 Modified gene-silencing nucleic acid molecules and uses thereof |
| 03/24/2005 | CA2551022A1 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 03/24/2005 | CA2538895A1 Factor ixa specific antibodies displaying factor viiia like activity |
| 03/24/2005 | CA2538883A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 03/24/2005 | CA2538843A1 Animal model for protease activity and liver damage |
| 03/24/2005 | CA2538495A1 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538484A1 Novel endosperm-specific plant promoter for cultivated plants |
| 03/24/2005 | CA2538461A1 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538442A1 Eukaryotic genes for modulating cell cycle progression |
| 03/24/2005 | CA2538314A1 Dihydroflavonol-4-reductase |
| 03/24/2005 | CA2538137A1 Method for gene identification signature (gis) analysis |
| 03/24/2005 | CA2538086A1 Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence |
| 03/24/2005 | CA2538082A1 Assay for sars coronavirus by amplification and detection of the replicase sequence |
| 03/24/2005 | CA2537931A1 Multi-antigen vectors for melanoma |
| 03/24/2005 | CA2537217A1 Therapeutic binding molecules |
| 03/24/2005 | CA2536989A1 Lawsonia intracellularis subunit vaccine |
| 03/24/2005 | CA2536931A1 Method of preparation of pharmaceutically grade plasmid dna |
| 03/24/2005 | CA2535710A1 Alcohol dehydrogenases with increased solvent and temperature stability |
| 03/24/2005 | CA2526720A1 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/23/2005 | EP1517253A2 Method for design support of functional nucleic acids |
| 03/23/2005 | EP1517178A1 A process for preparing peptide nucleic acid probe using monomeric photoacid generator |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516931A2 DSRNA-mediated regulation of gene expression in plants |
| 03/23/2005 | EP1516930A1 Cellular model of tauopathies for lead identification and drug discovery |
| 03/23/2005 | EP1516929A2 Method for linking sequences of interest |
| 03/23/2005 | EP1516928A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 03/23/2005 | EP1516927A1 Method for cloning and expression of SbfI restriction endonuclease and SbfI methylase in E. coli |
| 03/23/2005 | EP1516925A1 Generation of human embryonic stem cells from triploid zygotes |
| 03/23/2005 | EP1516924A1 Generation of human embryonic stem cells from triploid zygotes |
| 03/23/2005 | EP1516665A1 A method of immobilizing and stretching a nucleic acid on a substrate |
| 03/23/2005 | EP1516629A2 Humanized anti CD-11a antibodies |
| 03/23/2005 | EP1516274A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/23/2005 | EP1516190A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 03/23/2005 | EP1516186A1 A method for the detection of apoptosis |
| 03/23/2005 | EP1516184A2 Cell penetrating peptides |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1516061A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 03/23/2005 | EP1516059A2 Method for the production of sulphur-containing fine chemicals by fermentation |
| 03/23/2005 | EP1516058A2 Recombinant measles viruses expressing epitopes of antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 03/23/2005 | EP1516057A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 03/23/2005 | EP1516056A2 Thioesterase-related nucleic acid sequences and methods of use for the production of plants with modified fatty acid composition |
| 03/23/2005 | EP1516055A2 Fiber shaft modifications for efficient targeting |
| 03/23/2005 | EP1516053A2 Xylanases, nucleic adics encoding them and methods for making and using them |
| 03/23/2005 | EP1516052A1 Immunomodulation using altered dendritic cells |
| 03/23/2005 | EP1516051A2 Intron double stranded rna constructs and uses thereof |
| 03/23/2005 | EP1516050A2 Generation of plants with improved pathogen resistance |
| 03/23/2005 | EP1516049A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2005 | EP1516048A2 Protein glycosylation modification in pichia pastoris |
| 03/23/2005 | EP1516047A1 Purified pkb ser 473 kinase and uses thereof |
| 03/23/2005 | EP1516046A2 Genes encoding baeyer-villiger monooxygenases |
| 03/23/2005 | EP1516044A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 03/23/2005 | EP1515991A2 Pain signaling molecules |
| 03/23/2005 | EP1515990A2 Antagonists of cxcr3-binding cxc chemokines |
| 03/23/2005 | EP1515989A1 Immunogenic conjugates |
| 03/23/2005 | EP1515988A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 03/23/2005 | EP1515987A2 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 03/23/2005 | EP1515986A1 Improved method of producing an aspartic protease in a recombinant host organism |
| 03/23/2005 | EP1515985A2 Methods of screening molecular libraries for active molecules that restore the function of mutant p53 |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | EP1515752A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 03/23/2005 | EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515601A2 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 03/23/2005 | EP1461596A4 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips |
| 03/23/2005 | EP1421182A4 Methods of inducing differentiation of stem cells |
| 03/23/2005 | EP1415152A4 Methods, apparatus, and computer programs for verifying the integrity of a probe |